Vitamin d-enhanced multi-micronutrient supplement for reducing endometriosis and anemia

Overview

This solution integrates 1000 IU of Vitamin D with a hemopoietic multi-micronutrient supplement to address the dual challenges of endometriosis and anemia among women of reproductive age. Vitamin D is known for its anti-inflammatory and immunomodulatory effects, making it an ideal candidate to modulate immune responses and reduce inflammation. This combination aims to synergistically reduce the symptoms of endometriosis while simultaneously supporting hemopoietic functions to combat anemia.

Technical specifications

The supplement includes:

• Vitamin D3 (1000 IU): Enhances anti-inflammatory and immunomodulatory actions, regulating inflammatory cytokines and inhibiting proinflammatory cell proliferation.
• Multi-micronutrient blend: Selected for optimal support of erythropoiesis and hemopoietic function, addressing iron deficiency and related anemia.
• Targeted biomarkers for assessment: Hb, ferritin, sTfR, hepcidin, IL-6, TNFa, IL-1β, which are crucial for evaluating the supplement's efficacy in reducing inflammation and improving blood health.

Technology readiness level

This solution has reached Technology Readiness Level 6, having been validated in relevant environments. A forthcoming randomized double-blind, community-based control trial will further test its efficacy in reducing endometriosis and anemia, providing robust data for potential clinical applications.